Vaccine focus reduced in platform’s profit push

An ASX-listed pharmacy engagement company will shift focus amid changes to vaccine uptake in the US Pharmacy management platform Adheris Health – formerly MedAdvisor – plans to reduce its reliance on vaccines after their contribution to revenue dropped by more than half in two years. The US-focused newly named platform produced a roadshow presentation showing